Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Income-Before-Tax" stands at 8.24 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 3.51 Billion EUR for the item "Income Before Tax" represents an increase of 139.13 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 3.51 Billion EUR for the item "Income Before Tax" represents a decrease of -2.04 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 8.24 Billion EUR for the item "Income Before Tax" represents a decrease of -0.88 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 70.04 percent compared to the value the year prior.
The 1 year change in percent is 70.04.
The 3 year change in percent is 5.45.
The 5 year change in percent is -34.56.
The 10 year change in percent is 29.88.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Income Before Tax | 905,699,262,464.00 |
![]() | Johnson & Johnson - Income Before Tax | 486,508,953,600.00 |
![]() | AbbVie Inc - Income Before Tax | 399,570,305,024.00 |
![]() | Roche Holding AG - Income Before Tax | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Income Before Tax | 280,205,508,085.11 |